Human Genome Epidemiology Literature Finder
|
Records 1 - 5 (of 5 Records) |
| Query Trace: Thyroid Neoplasms and DIO2[original query] |
|---|
| Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer. British journal of clinical pharmacology 2014 Nov 78 (5): 1067-75. Santoro Ana B, Vargens Daniela D, Barros Filho Mateus de Camargo, Bulzico Daniel A, Kowalski Luiz Paulo, Meirelles Ricardo M R, Paula Daniela P, Neves Ronaldo R S, Pessoa Cencita N, Struchine Claudio J, Suarez-Kurtz Guilher |
| A study of the role of DIO1 and DIO2 polymorphism in thyroid cancer and drug response to therapy in the Saudi population. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society 2019 9 27 (6): 841-845. AlRasheed Maha M, AlAnzi Ashwaq, AlShalhoub Rawan, Abanmy Norah, Bakheet Da |
| Association between TSH suppression therapy and type 2 deiodinase gene polymorphism in differentiated thyroid carcinoma. Endokrynologia Polska 2023 7 . Xiaoke Zheng, Lichang Zhong, Tianjiao Zhou, Feng Zhao, Bin Ch |
| Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone. Thyroid : official journal of the American Thyroid Association 2023 1 . Luongo Cristina, De Stefano Maria Angela, Ambrosio Raffaele, Volpe Fabio, Porcelli Tommaso, Golia Valeria, Bellevicine Claudio, Troncone Giancarlo, Masone Stefania, Damiano Vincenzo, Matano Elide, Klain Michele, Schlumberger Martin, Salvatore Domeni |
| Determination of Frequency of Type 2 Deiodinase Thr92Ala Polymorphism (rs225014) in I-treated Differentiated Thyroid Cancer Patients Undertaking L-thyroxine (L-T4) Suppression Therapy. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India 2024 5 39 (1): 24-28. Smita Gawandi, Kumarasamy Jothivel, Savita Kulkar |
- Page last reviewed:Feb 1, 2024
- Content source: